Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate
KV Chalam, Vijay Khetpal, Chirag J PatelDepartment of Ophthalmology, University of Florida Jacksonville, FL, USAIntroduction: Pseudophakic cystoid macular edema is a common cause of poor vision after cataract surgery, and topical corticosteroids and nonsteroidal anti-inflammatory drugs are used for...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1fb01691647247e4878168f7d59b23cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1fb01691647247e4878168f7d59b23cd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1fb01691647247e4878168f7d59b23cd2021-12-02T02:02:43ZSpectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate1177-54671177-5483https://doaj.org/article/1fb01691647247e4878168f7d59b23cd2012-01-01T00:00:00Zhttp://www.dovepress.com/spectral-domain-optical-coherence-tomography-documented-rapid-resoluti-a9120https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483KV Chalam, Vijay Khetpal, Chirag J PatelDepartment of Ophthalmology, University of Florida Jacksonville, FL, USAIntroduction: Pseudophakic cystoid macular edema is a common cause of poor vision after cataract surgery, and topical corticosteroids and nonsteroidal anti-inflammatory drugs are used for its treatment. We investigated the effectiveness of difluprednate (Durezol®, recently approved by the US Food and Drug Administration) in the treatment of cystoid macular edema, assisted with spectral domain optical coherence tomography (SD-OCT).Case report: A 63-year-old African-American woman presented 6 weeks after uneventful cataract surgery in her left eye with decreased vision and associated distortion of the central visual field. Fluorescein angiogram and SD-OCT confirmed pseudophakic cystoid macular edema. Difluprednate was topically administered twice daily and monitored with serial imaging. Resolution was noted after 1 month of topical therapy, with improvement in visual acuity and resolution of distortion.Conclusion: Difluprednate is an effective treatment for patients with severe pseudophakic cystoid macular edema. SD-OCT allows the physician to monitor resolution of the macular edema easily.Keywords: cystoid macular edema, difluprednate, spectral domain optical coherence tomography, pseudophakicChalam KVKhetpal VPatel CJDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2012, Iss default, Pp 155-158 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ophthalmology RE1-994 |
spellingShingle |
Ophthalmology RE1-994 Chalam KV Khetpal V Patel CJ Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate |
description |
KV Chalam, Vijay Khetpal, Chirag J PatelDepartment of Ophthalmology, University of Florida Jacksonville, FL, USAIntroduction: Pseudophakic cystoid macular edema is a common cause of poor vision after cataract surgery, and topical corticosteroids and nonsteroidal anti-inflammatory drugs are used for its treatment. We investigated the effectiveness of difluprednate (Durezol®, recently approved by the US Food and Drug Administration) in the treatment of cystoid macular edema, assisted with spectral domain optical coherence tomography (SD-OCT).Case report: A 63-year-old African-American woman presented 6 weeks after uneventful cataract surgery in her left eye with decreased vision and associated distortion of the central visual field. Fluorescein angiogram and SD-OCT confirmed pseudophakic cystoid macular edema. Difluprednate was topically administered twice daily and monitored with serial imaging. Resolution was noted after 1 month of topical therapy, with improvement in visual acuity and resolution of distortion.Conclusion: Difluprednate is an effective treatment for patients with severe pseudophakic cystoid macular edema. SD-OCT allows the physician to monitor resolution of the macular edema easily.Keywords: cystoid macular edema, difluprednate, spectral domain optical coherence tomography, pseudophakic |
format |
article |
author |
Chalam KV Khetpal V Patel CJ |
author_facet |
Chalam KV Khetpal V Patel CJ |
author_sort |
Chalam KV |
title |
Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate |
title_short |
Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate |
title_full |
Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate |
title_fullStr |
Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate |
title_full_unstemmed |
Spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate |
title_sort |
spectral domain optical coherence tomography documented rapid resolution of pseudophakic cystoid macular edema with topical difluprednate |
publisher |
Dove Medical Press |
publishDate |
2012 |
url |
https://doaj.org/article/1fb01691647247e4878168f7d59b23cd |
work_keys_str_mv |
AT chalamkv spectraldomainopticalcoherencetomographydocumentedrapidresolutionofpseudophakiccystoidmacularedemawithtopicaldifluprednate AT khetpalv spectraldomainopticalcoherencetomographydocumentedrapidresolutionofpseudophakiccystoidmacularedemawithtopicaldifluprednate AT patelcj spectraldomainopticalcoherencetomographydocumentedrapidresolutionofpseudophakiccystoidmacularedemawithtopicaldifluprednate |
_version_ |
1718402696960016384 |